COPD
Conditions
Keywords
kinesio taping, COPD, functional capacity, pulmonary functions, pulmonary rehabilitation
Brief summary
The purpose of this study was to investigate the effect of kinseio taping on functional capacity, pulmonary functions, respiratory muscle strength, severity of dyspnea, severity of fatigue in Chronic Obstructive Pulmonary Disease (COPD). Assessment of patients was done baseline and 6th week. Eligible patients for the study randomly allocated to Kinesio Taping Group (KTG), or Control Group (CG). Both groups received three different deep breathing exercises (diaphragmatic, thoracic, and lateral basal), each consisting of three sets of 10 repetitions, with 30 seconds of rest between each set. KTG also received thoracic kinesio taping application.
Interventions
OTHERKinesio Taping
The material used for thoracic kinesio taping application was Kinesio® Tex Gold™ (Kinesio Holding. Patients were instructed to sit upright on an armless chair with no back support, with knees flexed to 90 degrees, feet on the floor and arms relaxed. Kinesio tape was applied anteriorly and posteriorly to facilitate respiratory muscles (primarily diaphragm) along the subcostal area. Additionally, two more kinesio tapes were applied to upper trapezius and scalene muscles' area which lies between neck and acromion at both sides (left and right).
Three different deep breathing exercises (diaphragmatic, thoracic, and lateral basal), each consisting of three sets of 10 repetitions, with 30 seconds of rest between each set.
Sponsors
Dokuz Eylul University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Masking description
An assessor who was blinded to treatment groups assessed clinical outcomes before the treatment process. The same assessor was also repeated assessments at 6th week (at the end of treatment process)
Eligibility
Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* aged 40 years and older, * having stage II-III COPD diagnosis according to GOLD system and BODE Index by chest physician, * unwilling to participate in any kind of pulmonary rehabilitation program for COPD, * able to read, write, and understand Turkish; and * willing and able to attend the study.
Exclusion criteria
* being in COPD exacerbation period, * having neurological or musculoskeletal problems that would affect physical mobility, * having unstable, severe heart disease(s) (heart failure, unstable hypertension, previous angina pectoris or myocardial infarction, heart valve problems), * having scar, lesion or incision in the area of kinesio tape application, * previous use of kinesio tape, * having skin sensitivity against kinesio tape, * malignancy, * having mental and cognitive disorders that would affect cooperation.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in functional capacity | Baseline, 6th week | Six-minute walk test (6MWT) is a valid, reliable and useful test for assessing functional capacity of COPD patients. This test assesses distance walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in pulmonary functions | Baseline, 6th week | Pulmonary function test (PFT) is a generic term used to indicate a battery of studies or maneuvers that may be performed using standardized equipment to measure lung function. |
| Change in respiratory muscle strength | Baseline, 6th week | Measurement of respiratory muscle strength is useful in order to detect respiratory muscle weakness and to quantify its severity. Respiratory muscle strength is assessed by mouth pressures sustained for 1 s during maximaş static manoeuvre against a closed shutter. |
| Change in severity of dyspnoea | Baseline, 6th week | Modified Medical Research Council (mMRC) dyspnea scale is a valid and reliable test for measuring the severity of dyspnea of COPD patients. This scale ranges from 0 to 4. A higher value represents a worse outcome. |
| Change in severity of fatigue | Baseline, 6th week | Modified Borg Scale (MBS) is a useful scale for severity of fatigue. This scale ranges from 0 to 10. A higher value represents a worse outcome (0=not at all, 10=maximal). |
Countries
Turkey (Türkiye)
Outcome results
None listed